“The National Institutes of Health (NIH) deleted a webpage from 2004 detailing research into vaccine efficacy against the monkeypox virus which included Anthony Fauci praising the findings as “important” and referencing a potential ‘bioterror threat involving smallpox,'” The National Pulse revealed.
— TexasLindsay™ (@TexasLindsay_) June 8, 2022
The webpage can be accessed through an archived version of the National Institutes of Health (NIH) website, which reveals a press release from March 10th, 2004: “Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox.”
The current link shows users the message “the page you’re looking for isn’t available.”
The webpage states:
A mild, experimental smallpox vaccine known as modified vaccinia Ankara (MVA) is nearly as effective as the standard smallpox vaccine in protecting monkeys against monkeypox, a study by researchers of the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has found. Monkeypox is used to test the effectiveness of a smallpox vaccine because of its similarity to the smallpox virus. The study appears in the March 11 issue of Nature.
“These findings are important to the search for a replacement vaccine for people with health conditions that would prevent them from using the current smallpox vaccine,” says Anthony S. Fauci, M.D., director of NIAID. Currently, Dryvax is the only commercially available smallpox vaccine in the United States. “In addition, because an initial MVA injection may help lessen the side effects experienced from Dryvax, MVA may serve as an important pre-vaccine for large-scale vaccination efforts in the event of a bioterror threat involving smallpox.”
NIAID’s Bernard Moss, M.D., Ph.D., the senior author on the paper, adds, “This study shows that the MVA vaccine holds great promise as an alternative to the current vaccine. Although MVA may not quite equal Dryvax in its effectiveness, it did extraordinarily well, with all of the monkeys who were vaccinated with MVA surviving a potentially lethal monkeypox infection and, aside from a few minor lesions, showing no clinical signs of disease.”
The National Pulse noted:
Fauci was reacting to the study “Immunogenicity of a Highly Attenuated MVA Smallpox Vaccine and Protection Against Monkeypox,” whose abstract also warns of the “potential use of smallpox as a biological weapon”:
“The potential use of smallpox as a biological weapon has led to the production and stockpiling of smallpox vaccine and the immunization of some healthcare workers.”
The study’s abstract continues, describing “another public health goal is the licensing of a safer vaccine” to treat smallpox:
As vaccines can no longer be tested for their ability to prevent smallpox, licensing will necessarily include comparative immunogenicity and protection studies in non-human primates. Here we compare the highly attenuated modified vaccinia virus Ankara (MVA) with the licensed Dryvax vaccine in a monkey model.
The deleted study follows The National Pulse unearthing the Wuhan Institute of Virology’s recent research assembling strains of the monkeypox virus to be able to conduct PCR tests. It also comes amidst the NIAID administering a $10 million grant to fund research into additional cures for monkeypox shortly before the current outbreak began.
This also comes on the heels of a tabletop exercise simulating a global pandemic involving an unusual strain of monkeypox virus.
The World Health Organization (WHO) declared monkeypox a global emergency.
— DailyNoah.com (@DailyNoahNews) July 23, 2022